...
首页> 外文期刊>International journal of infectious diseases : >Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000–2017
【24h】

Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000–2017

机译:瑞典病毒A71和Coxsackievirus A16基因型/亚因型在泰国的手中患者中的纵向研究A16基因型/亚型替代品,2000-2017

获取原文
           

摘要

Background Enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16) are the major causative agents of hand, foot and mouth disease (HFMD) worldwide, particularly in the Asia-Pacific region. Several strains have emerged, circulated, and faded out over time in recent decades. This study investigated the EV-A71 and CV-A16 circulating strains and replacement of genotypes/subgenotypes in Thailand during the years 2000–2017. Methods The complete VP1 regions of 92 enteroviruses obtained from 90 HFMD patients, one asymptomatic adult contact case, and one encephalitic case were sequenced and investigated for serotypes, genotypes, and subgenotypes using a phylogenetic analysis. Results The 92 enterovirus isolates were identified as 67 (72.8%) EV-A71 strains comprising subgenotypes B4, B5, C1, C2, C4a, C4b and C5, and 25 (27.2%) CV-A16 strains comprising subgenotypes B1a and B1b. Genotypic/subgenotypic replacements were evidenced during the study period. EV-A71 B5 and C4a have been the major circulating strains in Thailand for more than a decade, and CV-A16 B1a has been circulating for almost two decades. Conclusions This study provides chronological data on the molecular epidemiology of EV-A71 and CV-A16 subgenotypes in Thailand. Subgenotypic replacement frequently occurred with EV-A71, but not CV-A16. Monitoring for viral genetic and subgenotypic changes is important for molecular diagnosis, vaccine selection, and vaccine development.
机译:背景技术肠道病毒A71(EV-A71)和CoxSackeivirus A16(CV-A16)是全球手部,脚和口腔疾病(HFMD)的主要致病药物,特别是在亚太地区。近几十年来,几个菌株出现了几个菌株,并随着时间的推移而褪色。本研究在2000-2017年期间研究了EV-A71和CV-A16循环菌株和泰国基因型/亚阈值的替代。方法采用90 HFMD患者的92个肠病病毒,一个无症状成人接触案例和一个脑膜炎,基因型和使用系统发育分析的血质分析进行测序的完整VP1区域。结果92个肠病毒分离物被鉴定为包含亚因素B4,B5,C1,C2,C4A,C4B和C5的亚型B4,B5,C1,C 2,C4A,C4B和C5,以及包含亚型型B1A和B1B的25(27.2%)CV-A16菌株。在研究期间证明了基因型/亚阈值替代品。 EV-A71 B5和C4A一直是泰国的主要循环菌株超过十年,CV-A16 B1A近二十年的流通。结论本研究提供了泰国EV-A71和CV-A16亚因素的分子流行病学的时间性数据。 ev-A71经常发生亚阈值替代,但不是CV-A16。用于病毒遗传和亚阈值的监测对于分子诊断,疫苗选择和疫苗发育是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号